SG10201802979VA - Immunological extract and method of production - Google Patents

Immunological extract and method of production

Info

Publication number
SG10201802979VA
SG10201802979VA SG10201802979VA SG10201802979VA SG 10201802979V A SG10201802979V A SG 10201802979VA SG 10201802979V A SG10201802979V A SG 10201802979VA SG 10201802979V A SG10201802979V A SG 10201802979VA
Authority
SG
Singapore
Prior art keywords
binding moiety
extract
nest
bird
mixture
Prior art date
Application number
Inventor
Kah Meng Lim
Original Assignee
Kah Meng Lim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kah Meng Lim filed Critical Kah Meng Lim
Priority to SG10201802979V priority Critical patent/SG10201802979VA/en
Priority to CA3096818A priority patent/CA3096818A1/en
Priority to KR1020207032491A priority patent/KR20210008345A/en
Priority to CN201980039090.6A priority patent/CN112469425A/en
Priority to JP2021505178A priority patent/JP2021521276A/en
Priority to SG11202009965XA priority patent/SG11202009965XA/en
Priority to PCT/SG2019/050200 priority patent/WO2019199232A1/en
Priority to US17/046,649 priority patent/US20210361720A1/en
Priority to AU2019250651A priority patent/AU2019250651A1/en
Publication of SG10201802979VA publication Critical patent/SG10201802979VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1732—Lectins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1725—Complement proteins, e.g. anaphylatoxin, C3a or C5a
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/204—Animal extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/50—Polysaccharides, gums
    • A23V2250/51—Polysaccharide
    • A23V2250/5114—Dextrins, maltodextrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00—Processes
    • A23V2300/14—Extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

IMMUNOLOGICAL EXTRACT AND METHOD OF PRODUCTION The present invention relates to a method of preparing an extract from edible bird's nest, a bird's nest extract and uses of the bird's nest extract. The method comprises preparing an edible bird's nest (EBN) mixture; and contacting the mixture with an extraction solution to bind a molecule in the mixture, wherein the extraction solution comprises at least one binding moiety selected from the group comprising an opsonin binding moiety, a complement protein binding moiety, a lectin binding moiety, a ficolin binding moiety, a collectin binding moiety, and a pentraxin binding moiety. (Figure 1) 40
SG10201802979V 2018-04-10 2018-04-10 Immunological extract and method of production SG10201802979VA (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SG10201802979V SG10201802979VA (en) 2018-04-10 2018-04-10 Immunological extract and method of production
CA3096818A CA3096818A1 (en) 2018-04-10 2019-04-10 Immunological extract and method of production
KR1020207032491A KR20210008345A (en) 2018-04-10 2019-04-10 Immunological extract and production method
CN201980039090.6A CN112469425A (en) 2018-04-10 2019-04-10 Immune extract and production method thereof
JP2021505178A JP2021521276A (en) 2018-04-10 2019-04-10 Immunological extract and manufacturing method
SG11202009965XA SG11202009965XA (en) 2018-04-10 2019-04-10 Immunological extract and method of production
PCT/SG2019/050200 WO2019199232A1 (en) 2018-04-10 2019-04-10 Immunological extract and method of production
US17/046,649 US20210361720A1 (en) 2018-04-10 2019-04-10 Immunological extract and method of production
AU2019250651A AU2019250651A1 (en) 2018-04-10 2019-04-10 Immunological extract and method of production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201802979V SG10201802979VA (en) 2018-04-10 2018-04-10 Immunological extract and method of production

Publications (1)

Publication Number Publication Date
SG10201802979VA true SG10201802979VA (en) 2019-11-28

Family

ID=68164877

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201802979V SG10201802979VA (en) 2018-04-10 2018-04-10 Immunological extract and method of production
SG11202009965XA SG11202009965XA (en) 2018-04-10 2019-04-10 Immunological extract and method of production

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11202009965XA SG11202009965XA (en) 2018-04-10 2019-04-10 Immunological extract and method of production

Country Status (8)

Country Link
US (1) US20210361720A1 (en)
JP (1) JP2021521276A (en)
KR (1) KR20210008345A (en)
CN (1) CN112469425A (en)
AU (1) AU2019250651A1 (en)
CA (1) CA3096818A1 (en)
SG (2) SG10201802979VA (en)
WO (1) WO2019199232A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201601905RA (en) * 2016-03-11 2017-10-30 Kah Meng Lim Extract And Method of Extraction

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003260286A1 (en) * 2002-09-10 2004-04-30 Natlmmune A/S Collectin-complement activating protein chimeras
CN1701789A (en) * 2005-05-13 2005-11-30 韩孝清 Nutrition replenisher containing sialic acid and its derivative
CN101835894A (en) * 2007-08-24 2010-09-15 肿瘤疗法科学股份有限公司 EBI3, DLX5, NPTXl and CDKN3 for target genes of lung cancer therapy and diagnosis
CN104168918A (en) * 2012-03-19 2014-11-26 德国癌症研究中心 B-cell receptor complex binding proteins containing T-cell epitopes
CN106235303A (en) * 2015-06-03 2016-12-21 莫智文 For producing the acidic group enzymatic method of edible Nidus collocaliae extract
CN104961833B (en) * 2015-07-21 2018-08-03 中国科学技术大学 A kind of people source NKp80-Fc fusion proteins and preparation method thereof and the application in oncotherapy
WO2017012088A1 (en) * 2015-07-22 2017-01-26 陈天煌 Extraction method for bird's nest extract
SG10201601905RA (en) * 2016-03-11 2017-10-30 Kah Meng Lim Extract And Method of Extraction
CN107868808B (en) * 2017-11-01 2021-03-02 金腰燕（广州）食品有限公司 Method for improving free acid in cubilose saliva
GB201807178D0 (en) * 2018-05-01 2018-06-13 Univ Ulster A method of diagnosing or prognosing a neurological disorder
KR20210073520A (en) * 2018-09-05 2021-06-21 포세이다 테라퓨틱스, 인크. Allogeneic cell compositions and methods of use thereof

Also Published As

Publication number Publication date
CA3096818A1 (en) 2019-10-17
JP2021521276A (en) 2021-08-26
SG11202009965XA (en) 2020-11-27
US20210361720A1 (en) 2021-11-25
CN112469425A (en) 2021-03-09
KR20210008345A (en) 2021-01-21
AU2019250651A1 (en) 2020-11-26
WO2019199232A1 (en) 2019-10-17

Similar Documents

Publication Publication Date Title
MX2021003056A (en) Functional mung bean-derived compositions.
MX2021004443A (en) A process for making a meat analogue product.
MX2015013178A (en) Method for protein extraction from oil seed.
NZ628625A (en) Polypeptides binding to human complement c5
BR112016020517A2 (en) lipid production method using ss-ketoacyl acp synthase
PH12018501771A1 (en) Nut based liquid creamers and method of making thereof
MX2017000014A (en) METHOD FOR PRODUCING MEDIUM-CHAIN FATTY ACID USING ß-KETOACYL-ACP SYNTHASE.
MY189662A (en) Edible bird's nest extract and method of extraction
SG10201802979VA (en) Immunological extract and method of production
MX2018002830A (en) Process for the extraction of silica.
EP4272822A3 (en) Adamts binding immunoglobulins
MX2019011609A (en) Method for the procedurally economical removal/fractionation of constituents of vegetal starting material, and the production and use of same.
MX2021010118A (en) Fortified milk compositions and their processes of preparation.
MX2020002552A (en) Methods and compositions for preparing surfactant protein d (sp-d).
MX2020002551A (en) Methods, compositions and cells for preparing surfactant protein d (sp-d).
MX2021012471A (en) Cd40 specific dna aptamers as vaccine adjuvants.
Kryštufek et al. Rescue eastern Europe’s collections
CY1123003T1 (en) SELECTIVELY DEGLYCOSYLATED VITAMIN D-BINDING PROTEIN (GCMAF) AND Cholecalciferol (CALCIOL) AS ALSO METHOD OF PREPARATION
CN203986158U (en) A kind of conchoidal dancing brassiere
EA201991083A1 (en) PROCESSED PROTEIN PRODUCT
MAKSIMOV The XXVIIth International Mineral Processing Congress (Part 1)
TH170388B (en) Method for producing lipids using acyl-acp Tai O Esterres
TH1801005347A (en) A second type of bonomorphogenetic protein in the cytoplasm from the Bacterial cells by osmotic shock technique
Green Black Elk, Mexican Joe & Buffalo Bill-The Real Story
TH168041B (en) Conjugated polysaccharides - conjugated proteins with an enhanced immune response. And the high-speed process of such preparation